Floatz logo

SUFENTANYL

Traumatic Brain Injury

Universitas Jenderal SoedirmanSmall moleculePhase 4 / ApprovedActive
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
73/ 100

Competitive context

92 Active assets in the Traumatic Brain Injury cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
PROPRANOLOL
Tanta University
Phase 4BBB
NEPENTHE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
N-Acetyl-L-Cysteine
HonorHealth Research Institute
Phase 2BB

View all 50 →

Same molecule, other indications

SUFENTANYL is also rated in:

chronic pain syndromeDormant
BB
Indicative ·
69 / 100
View asset →
AnalgesicsDormant
BB
Indicative ·
68 / 100
View asset →
Post Operative PainDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →